Navigation Links
Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Date:12/3/2008

to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with ER alpha activation and that ER beta blocks the growth promoting effects on breast cancer cells. Bionovo recognized the opportunity to commercialize a product that would be equally effective, with an improved safety profile compared to traditional hormone therapy. The clinical trial results have been evaluated by an independent Data and Safety Monitoring Board and the drug candidate has passed through a standard two-phase examination for safety.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or mainta
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Many new dentists ... can do to ensure that their practice will be a ... the basic supplies they use the most can make all ... many dentists have recently discovered that purchasing discount dental ... According to successful dentists across ...
(Date:7/24/2014)... KIRKLAND, Wash. , July 24, 2014 ... exhibiting at the 2014 National Association of State Veterans ... Carolina . The goal of the NASVH is ... receives the benefits, services, long term health care and ... sacrifice. With the InSite® Remote Dispensing ...
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
Breaking Medicine Technology:Dental Supplies Online is Key to Dental Success...Really! 2Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3
... Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that Bruce Cozadd ... 35th Annual Health Care Conference on Monday, May 3, 2010 at ... Boston, MA. , , , ... of the presentation may be accessed from the Investors section of the Jazz ...
... April 26 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... announced Paul F. Truex , Anthera,s President and Chief Executive Officer ... Boston, MA on Monday, May 3, 2010 at ... , , ...
Cached Medicine Technology:Anthera Pharmaceuticals to Present at Deutsche Bank Securities' 35th Annual Health Care Conference 2
(Date:7/24/2014)... A new study led by the Translational Genomics ... bacteria, viruses and the immune system during HIV infection. ... potential to infect others based on their blood ... virus in their semen despite having low levels in ... of the virus can be found in different parts ...
(Date:7/24/2014)... July 24, 2014 In signing ... President Obama cited the Atlanta BeltLine Workforce Partnership ... from across the country ( http://www.whitehouse.gov/ready-to-work ). ... essential pillar of U.S. economic strategy and profiled ... “This recognition from President Obama highlights the power ...
(Date:7/24/2014)... BOSTON -- A new study has shown that it is ... by measuring the short-term effects of that same exposure. The ... , will make it possible to develop simpler and cheaper ... , Despite an overall decrease in incidence of ... be diagnosed with the disease in their lifetime, and around ...
(Date:7/24/2014)... the Human Papillomavirus Vaccination (HPV) even after becoming ... test results than those who were never vaccinated. ... Transmitted Diseases . , Researchers from Boston ... Medicine conducted a cross-sectional study of 235 women ... testing. HPV status and demographic and behavioral characteristics ...
(Date:7/24/2014)... York, New York (PRWEB) July 24, 2014 ... testosterone lawsuit ( http://www.drugbot.com/testosterone/lawsuit/ ) against the manufacturer ... of the risks associated with the low testosterone ... complaint, which was filed in the Ontario Superior ... alleges that use of low testosterone therapy is ...
Breaking Medicine News(10 mins):Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Researchers discover new way to determine cancer risk of chemicals 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 3
... related to aggressive cancers can actually improve the efficacy ... Priority Report in Cancer Research , published by ... Hu antigen R (HuR), is a stress response protein ... certain experimental settings, pancreatic cancer cells that overexpressed HuR ...
... ... receives U.S. FDA Approval , ... (Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors, ... in the European Union, Brazil, Argentina and more than 26 countries worldwide is a ...
... Free Webcast on Making a Smooth Transition to the EMR ... (NYSE: IRM ), the global leader in information ... tips during an upcoming Webcast for how healthcare providers can ... In this free, hour-long Webcast, attendees will learn the chief ...
... Better diagnosis, treatments behind decrease, researchers say , WEDNESDAY, June ... to fewer deaths from the rupture of a blood vessel ... Known as a subarachnoid hemorrhage, this kind of rupture leads ... thin tissue that covers the brain. It can occur spontaneously, ...
... Information Exchange for Medicaid Beneficiaries, Powered by MedPlus Centergy(TM) ... Access to Patient Information and Better Health Outcomes , ... The Department of Health Care Finance, DHCF, the District,s ... information technology subsidiary of Quest Diagnostics Incorporated (NYSE: ...
... following was released today by 1st Class Kids: , ... Tournament to raise money in support of continued obesity ... filled with TopGolf Skills Challenges, game play, live entertainment, ... the need to raise awareness about childhood obesity. Additionally, ...
Cached Medicine News:Health News:Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 2Health News:New Option for Erasing Wrinkles 2Health News:New Option for Erasing Wrinkles 3Health News:New Option for Erasing Wrinkles 4Health News:Best Practices for Hospitals Moving to Electronic Medical Records 2Health News:Fewer Deaths Occurring From Brain Bleeds 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 2Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 3Health News:Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology 4
The automated and pivoting M2 hand-piece incorporates two powerful, independent electric motors : one controls the blade oscillation at 15,000 RPM and the second controls the high-torque advance of t...
... potential for quality vision with ACRYSOF IQ ... spherical aberration by addressing the effects of ... without increasing edge thickness. Human corneal ... that provides improved image quality.,MTF (measured in ...
... Advanced Optics Aspheric Lens System can ... IOL all your cataract patients will ... quality and contrast sensitivity. With a ... should consistently deliver superior optical performance ...
... was designed to be as easy to ... shares many of its features, including CPR ... HeartStart Home Defibrillator is an automated external ... use by untrained users. Although small and ...
Medicine Products: